Loading
Latest filing published 21 Nov 2017 for 9 METERS BIOPHARMA, INC..
No signal scores available.
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Steven C. Barre discloses dealings in 3 companies, chiefly Jacuzzi Brands Inc, Whitney Information Network Inc and 9 Meters Biopharma, Inc. Over a trading history stretching from 17 March 2006 to 9 November 2017, the count stands at 17 filings.
In open-market terms, that means 5 purchases worth €11k on one side and 5 sales worth €112k on the other. The net balance comes to €101k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 7 share grants.
In size, the median ticket on the buying side is €1,178. After 5 purchases with a full 90-day history, the hit rate stands at 40% and the median 90-day move at -33.1%. Past outcomes like these are no guarantee of what comes next.
On 21 November 2017 came the latest disclosure, a share grant in 9 Meters Biopharma, Inc. The last purchase on record was published on 18 April 2011, which is 5,668 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations